Chronos Archive seal
The Human Record

Wilma Mankiller

Case HR-ML052 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
November 18, 1945 – April 6, 2010
Synthetic DOB
1991-11-18
Index visit
2026-03-09 at age 34
Synthetic MRN
HR-ML052-SYN

Teaching objective: New generalized myasthenia gravis in a 34-year-old Cherokee woman recovering from major trauma, on the 2016 and 2020 international consensus guidance for MG and the KDIGO 2025 ADPKD guideline. Drooping eyelids, double vision and fatigable weakness lead to the ice pack test, acetylcholine receptor antibodies (with MuSK held in reserve), repetitive nerve stimulation (with single-fiber EMG held in reserve), chest CT for thymoma, TSH, and forced vital capacity and negative inspiratory force, with the warning signs of myasthenic crisis. Treatment covers pyridostigmine, prednisone started low and raised slowly, azathioprine as a steroid-sparing agent after TPMT and infection screening, vaccination before immunosuppression, early thymectomy under the MGTX evidence, the place of newer targeted therapies such as efgartigimod and eculizumab, and the medicines to avoid in myasthenia gravis. Her documented hereditary polycystic kidney disease adds eGFR, urine albumin, kidney ultrasound with total kidney volume and the Mayo Imaging Classification, home blood pressure, water intake and avoiding NSAIDs. Care is culturally safe, with laboratory work through Cherokee Nation Health Services near her home and her own Cherokee medicine respected. Her documented diagnosis of myasthenia gravis less than a year after the 1979 crash, and her recovery with the help of Cherokee medicine people, surgery and drug therapy, frame the episode.

Historical timeline

DateEventClaims
November 18, 1945Born in Tahlequah, Oklahoma.CLM-0001
1956 or 1957Family relocates from Adair County to San Francisco.CLM-0002
1969The occupation of Alcatraz shapes her activism.CLM-0003
1976 or 1977Returns to Mankiller Flats in Adair County and works for the Cherokee Nation.CLM-0004
1979 (1978 in one account)Near-fatal head-on car crash; about 17 operations follow.CLM-0005, CLM-0006
1981Returns to work with the Cherokee Nation after treatment for myasthenia gravis, diagnosed less than a year after the crash.CLM-0007
December 1985Becomes principal chief of the Cherokee Nation.CLM-0008
1990Kidney transplant for hereditary polycystic kidney disease.CLM-0009
1993Publishes her autobiography.CLM-0012
1996Treated for lymphoma.CLM-0010
1998Second kidney transplant; Presidential Medal of Freedom.CLM-0010, CLM-0012
1999Treated for breast cancer.CLM-0011
March 2, 2010Announces a diagnosis of advanced pancreatic cancer.CLM-0013
April 6, 2010Dies at her home in rural Adair County.CLM-0014

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Wilma Pearl Mankiller was born on November 18, 1945, in Tahlequah, Oklahoma, the capital of the Cherokee Nation, the sixth of eleven children; her father was a full-blood Cherokee. A Cherokee Nation release gave her birthplace as the W.W. Hastings Indian Hospital in Tahlequah; the Oklahoma Hall of Fame says she was born at Rock Mountain in Adair County.
Anchors the true birth date and her Cherokee identity. The birthplace differs between sources; Tahlequah is used.
confirmed Wilson LD. Mankiller, Wilma Pearl (1945-2010). The Encyclopedia of Oklahoma History and Culture supports
Brando E. Wilma Mankiller (1945-2010). Biographies supports
Ex-Cherokee chief Mankiller diagnosed with cancer. Cherokee Phoenix, March 3, 2010 supports
Wilma Mankiller, inducted 1994 disputes
HISTMED Master Roster v3 supports
D As a child she moved with her family from Mankiller Flats in Adair County to San Francisco under the Bureau of Indian Affairs relocation program (1956 or 1957 by different accounts); she later described the move as her own little Trail of Tears.
History before the episode; the sources give her age at the move as 10 or 11.
probable Wilson LD. Mankiller, Wilma Pearl (1945-2010). The Encyclopedia of Oklahoma History and Culture supports
Brando E. Wilma Mankiller (1945-2010). Biographies supports
Ex-Cherokee chief Mankiller diagnosed with cancer. Cherokee Phoenix, March 3, 2010 supports
D The occupation of Alcatraz Island in 1969 and her work with American Indian communities in California in the 1970s set the course of her activism.
History before the episode.
confirmed Wilson LD. Mankiller, Wilma Pearl (1945-2010). The Encyclopedia of Oklahoma History and Culture supports
Brando E. Wilma Mankiller (1945-2010). Biographies supports
D She returned to eastern Oklahoma with her two daughters in the later 1970s (1976 or 1977 by different accounts), worked for the Cherokee Nation, and lived on her grandfather's allotment, Mankiller Flats, in Adair County.
Anchors her home and work at the index date. Her daughters are not named and have no role in the modern episode.
confirmed Wilson LD. Mankiller, Wilma Pearl (1945-2010). The Encyclopedia of Oklahoma History and Culture supports
Mankiller, Wilma (b. 1945). Encyclopedia of the Great Plains supports
D In 1979 she was nearly killed in a head-on car crash on a curve, in which the driver of the other car, one of her best friends, died. She needed about 17 operations; accounts say her leg was barely saved from amputation and that she was told she might never walk again. The Oklahoma Hall of Fame dates the crash to 1978 and describes shattered legs, broken ribs and a crushed face.
The documented anchor for the history of major trauma in the modern episode. The month of the crash is not recorded in the sources read. The friend who died is not named in this record.
confirmed Mankiller, Wilma (b. 1945). Encyclopedia of the Great Plains supports
Ex-Cherokee chief Mankiller diagnosed with cancer. Cherokee Phoenix, March 3, 2010 supports
Cherokee Ex-Chief Wilma Mankiller Dies (summary of Associated Press) supports
Mankiller, Wilma. UXL Encyclopedia of World Biography (via Encyclopedia.com) supports
Wilma Mankiller, inducted 1994 disputes
D Her recovery was made harder by the emotional trauma of her friend's death in the crash.
Recorded as the published account states it; no mental health diagnosis is made or implied.
probable Mankiller, Wilma (b. 1945). Encyclopedia of the Great Plains supports
Fighting for her people, her health. News On 6, February 17, 2000 supports
D Less than a year after the crash, while still recovering, she was diagnosed with myasthenia gravis (dated 1980 in one reference account). With help from Cherokee medicine people, surgery and drug therapy, she recovered and returned to work with the Cherokee Nation in 1981; she later became a spokesperson for the Myasthenia Gravis Foundation.
The documented anchor for the modern episode. The type of surgery and the drugs are not named in the sources read; a thymectomy is therefore not recorded as history.
confirmed Fighting for her people, her health. News On 6, February 17, 2000 supports
Mankiller, Wilma. UXL Encyclopedia of World Biography (via Encyclopedia.com) supports
Mankiller, Wilma (b. 1945). Encyclopedia of the Great Plains supports
Wilma Mankiller, inducted 1994 supports
D She became the first woman deputy chief of the Cherokee Nation in August 1983 and principal chief in December 1985; she was elected in 1987, re-elected in 1991, and served until 1995, the first woman to lead the Cherokee Nation.
History after the episode.
confirmed Wilson LD. Mankiller, Wilma Pearl (1945-2010). The Encyclopedia of Oklahoma History and Culture supports
Brando E. Wilma Mankiller (1945-2010). Biographies supports
D Hereditary polycystic kidney disease, which she called her old nemesis, led to a kidney transplant in 1990, with a kidney donated by her brother; in 1991, a year after repeated hospital stays and the transplant, she won re-election with 82 percent of the vote.
The documented anchor for polycystic kidney disease in the modern episode. The donor is not named in this record. The type (autosomal dominant) is inferred from the description as hereditary and adult in onset.
confirmed Fighting for her people, her health. News On 6, February 17, 2000 supports
Mankiller, Wilma (b. 1945). Encyclopedia of the Great Plains supports
Ex-Cherokee chief Mankiller diagnosed with cancer. Cherokee Phoenix, March 3, 2010 supports
D The transplanted kidney was damaged by her treatment for lymphoma in 1996, and she had a second kidney transplant in 1998. Another account says ill health, including a second kidney operation and treatment for lymphatic cancer, led her to decline a third term in 1995.
Later history; the sources differ on the timing.
probable Fighting for her people, her health. News On 6, February 17, 2000 supports
Mankiller, Wilma (b. 1945). Encyclopedia of the Great Plains supports
D She was treated for breast cancer in 1999.
Later history. The year comes from a February 2000 article that says she was treated 'last year'.
probable Fighting for her people, her health. News On 6, February 17, 2000 supports
Ex-Cherokee chief Mankiller diagnosed with cancer. Cherokee Phoenix, March 3, 2010 supports
D Her autobiography, Mankiller: A Chief and Her People, written with Michael Wallis, was published in 1993; she received the Presidential Medal of Freedom in 1998. In the autobiography she wrote that she wanted to be remembered for emphasizing that 'we have indigenous solutions to our problems.'
History after the episode; her words anchor the culturally safe care plan.
confirmed Wilson LD. Mankiller, Wilma Pearl (1945-2010). The Encyclopedia of Oklahoma History and Culture supports
Brando E. Wilma Mankiller (1945-2010). Biographies supports
D On March 2, 2010, a news release announced that she had stage 4 metastatic pancreatic cancer; in it she wrote that she was mentally and spiritually prepared for the journey.
History only; not used in the modern episode and not foreshadowed.
confirmed Ex-Cherokee chief Mankiller diagnosed with cancer. Cherokee Phoenix, March 3, 2010 supports
Good Voice C. Former Cherokee Nation Chief Wilma Mankiller dies. Cherokee Phoenix, April 6, 2010 supports
D She died on the morning of April 6, 2010, at her home in rural Adair County, Oklahoma, aged 64, of pancreatic cancer.
Recorded as a fact; no detail of her last illness is used.
confirmed Good Voice C. Former Cherokee Nation Chief Wilma Mankiller dies. Cherokee Phoenix, April 6, 2010 supports
Brando E. Wilma Mankiller (1945-2010). Biographies supports
Wilson LD. Mankiller, Wilma Pearl (1945-2010). The Encyclopedia of Oklahoma History and Culture supports
HISTMED Master Roster v3 supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Drooping eyelids and double vision for six weeks, worse in the evening, with fatigable weakness of the arms and neck, tiring when chewing and a nasal voice after long talks; a disorder of the neuromuscular junction suspected resolved confirmed active
S Generalized myasthenia gravis, acetylcholine receptor antibody positive, MGFA class IIa, without thymoma; synthetic modern detail linked to her documented myasthenia gravis of 1980 active confirmed both_with_link CLM-0007
S Autosomal dominant polycystic kidney disease (hereditary, as she has described it), with normal kidney function; to be staged active confirmed both_with_link CLM-0009
S Recovery from major trauma in a head-on car crash last year: fractures of both legs, ribs and face, with many operations; walks independently, with a cane on rough ground active confirmed both_with_link CLM-0005
S Long-term glucocorticoid therapy for myasthenia gravis, with monitoring of glucose, blood pressure, weight, bone health, mood, sleep, eyes and infection active confirmed active CLM-0007
S Azathioprine as steroid-sparing therapy, with blood count and liver test monitoring active confirmed active CLM-0007
S Acquired absence of the thymus after robotic extended thymectomy for myasthenia gravis (pathology: thymic follicular hyperplasia, no thymoma) active confirmed active CLM-0007

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-03-09 Hemoglobin [Mass/volume] in Blood 12.8 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-03-09 Leukocytes [#/volume] in Blood by Automated count 6.9 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-03-09 Platelets [#/volume] in Blood by Automated count 262 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-03-09 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-03-09 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-03-09 Glucose [Mass/volume] in Serum or Plasma 88 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-03-09 Creatinine [Mass/volume] in Serum or Plasma 0.78 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-03-09 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 102 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-03-09 Calcium [Mass/volume] in Serum or Plasma 9.4 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 2026-03-09 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18 U/L
Reference 7-45 U/L
http://loinc.org · 1742-6
S 2026-03-09 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 U/L
Reference 8-43 U/L
http://loinc.org · 1920-8
S 2026-03-09 Albumin [Mass/volume] in Serum or Plasma 4.2 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2026-03-09 Thyrotropin [Units/volume] in Serum or Plasma 1.9 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 2026-03-09 Hemoglobin A1c/Hemoglobin.total in Blood 5.3%
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-03-09 Albumin/Creatinine [Mass Ratio] in Urine 14 mg/g
Reference Below 30 mg/g is normal (A1)
http://loinc.org · 9318-7
S 2026-03-09 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 31 ng/mL
Reference 30-100 ng/mL
http://loinc.org · 62292-8
S 2026-03-09 Forced vital capacity [Volume] Respiratory system 3.3 L
Reference Lower limit of normal about 2.9 L for her age, sex and height
http://loinc.org · 19870-5
S 2026-03-09 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 2026-03-23 Acetylcholine receptor binding Ab [Moles/volume] in Serum 6.8 nmol/L (high)
Reference 0.02 nmol/L or less is negative
http://loinc.org · 11034-6
S 2026-03-23 Forced vital capacity [Volume] Respiratory system 3.25 L
Reference Lower limit of normal about 2.9 L for her age, sex and height
http://loinc.org · 19870-5
S 2026-03-23 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2026-05-04 Hemoglobin [Mass/volume] in Blood 13.2 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-05-04 Leukocytes [#/volume] in Blood by Automated count 10.4 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-05-04 Platelets [#/volume] in Blood by Automated count 284 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-05-04 Potassium [Moles/volume] in Serum or Plasma 4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-05-04 Glucose [Mass/volume] in Serum or Plasma 104 mg/dL (high)
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-05-04 Creatinine [Mass/volume] in Serum or Plasma 0.76 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-05-04 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 105 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-05-04 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20 U/L
Reference 7-45 U/L
http://loinc.org · 1742-6
S 2026-05-04 Forced vital capacity [Volume] Respiratory system 3.48 L
Reference Lower limit of normal about 2.9 L for her age, sex and height
http://loinc.org · 19870-5
S 2026-05-04 DXA Femur [Z-score] Bone density -0.4
Reference Above -2.0 is within the expected range for age
http://loinc.org · 80934-3
S 2026-05-04 DXA Lumbar spine [Z-score] Bone density -0.7
Reference Above -2.0 is within the expected range for age
http://loinc.org · 85394-5
S 2026-05-04 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2026-07-13 Hemoglobin [Mass/volume] in Blood 12.6 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-07-13 Leukocytes [#/volume] in Blood by Automated count 6.2 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-07-13 Platelets [#/volume] in Blood by Automated count 250 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-07-13 Potassium [Moles/volume] in Serum or Plasma 4.3 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-07-13 Glucose [Mass/volume] in Serum or Plasma 96 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-07-13 Creatinine [Mass/volume] in Serum or Plasma 0.79 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-07-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 101 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-07-13 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26 U/L
Reference 7-45 U/L
http://loinc.org · 1742-6
S 2026-07-13 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 8-43 U/L
http://loinc.org · 1920-8
S 2026-07-13 Forced vital capacity [Volume] Respiratory system 3.4 L
Reference Lower limit of normal about 2.9 L for her age, sex and height
http://loinc.org · 19870-5
S 2026-07-13 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-10-12 Hemoglobin [Mass/volume] in Blood 12.9 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-10-12 Leukocytes [#/volume] in Blood by Automated count 5.4 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-10-12 Platelets [#/volume] in Blood by Automated count 238 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-10-12 Creatinine [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-10-12 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 99 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-10-12 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 23 U/L
Reference 7-45 U/L
http://loinc.org · 1742-6
S 2026-10-12 Hemoglobin A1c/Hemoglobin.total in Blood 5.6%
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-10-12 Albumin/Creatinine [Mass Ratio] in Urine 16 mg/g
Reference Below 30 mg/g is normal (A1)
http://loinc.org · 9318-7
S 2026-10-12 Forced vital capacity [Volume] Respiratory system 3.62 L
Reference Lower limit of normal about 2.9 L for her age, sex and height
http://loinc.org · 19870-5
S 2026-10-12 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-08-24 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 2026-08-24 Total score [AUDIT-C] 0 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-03-09Body height163 cm8302-2S
2026-03-09Body weight61.8 kg29463-7S
2026-03-09Body mass index (BMI) [Ratio]23.3 kg/m239156-5S
2026-03-09Systolic blood pressure126 mm[Hg]8480-6S
2026-03-09Diastolic blood pressure82 mm[Hg]8462-4S
2026-03-09Heart rate78 /min8867-4S
2026-03-09Respiratory rate16 /min9279-1S
2026-03-09Body temperature36.7 Cel8310-5S
2026-03-09Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-03-23Body height163 cm8302-2S
2026-03-23Body weight61.6 kg29463-7S
2026-03-23Body mass index (BMI) [Ratio]23.2 kg/m239156-5S
2026-03-23Systolic blood pressure124 mm[Hg]8480-6S
2026-03-23Diastolic blood pressure80 mm[Hg]8462-4S
2026-03-23Heart rate76 /min8867-4S
2026-03-23Respiratory rate16 /min9279-1S
2026-03-23Body temperature36.6 Cel8310-5S
2026-03-23Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-05-04Body height163 cm8302-2S
2026-05-04Body weight63.9 kg29463-7S
2026-05-04Body mass index (BMI) [Ratio]24.1 kg/m239156-5S
2026-05-04Systolic blood pressure128 mm[Hg]8480-6S
2026-05-04Diastolic blood pressure82 mm[Hg]8462-4S
2026-05-04Heart rate80 /min8867-4S
2026-05-04Respiratory rate16 /min9279-1S
2026-05-04Body temperature36.6 Cel8310-5S
2026-05-04Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-07-13Body height163 cm8302-2S
2026-07-13Body weight64.8 kg29463-7S
2026-07-13Body mass index (BMI) [Ratio]24.4 kg/m239156-5S
2026-07-13Systolic blood pressure124 mm[Hg]8480-6S
2026-07-13Diastolic blood pressure80 mm[Hg]8462-4S
2026-07-13Heart rate74 /min8867-4S
2026-07-13Respiratory rate14 /min9279-1S
2026-07-13Body temperature36.7 Cel8310-5S
2026-07-13Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-12Body height163 cm8302-2S
2026-10-12Body weight63.6 kg29463-7S
2026-10-12Body mass index (BMI) [Ratio]23.9 kg/m239156-5S
2026-10-12Systolic blood pressure118 mm[Hg]8480-6S
2026-10-12Diastolic blood pressure76 mm[Hg]8462-4S
2026-10-12Heart rate72 /min8867-4S
2026-10-12Respiratory rate14 /min9279-1S
2026-10-12Body temperature36.6 Cel8310-5S
2026-10-12Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-08-24Body height163 cm8302-2S
2026-08-24Body weight64.2 kg29463-7S
2026-08-24Body mass index (BMI) [Ratio]24.2 kg/m239156-5S
2026-08-24Systolic blood pressure120 mm[Hg]8480-6S
2026-08-24Diastolic blood pressure76 mm[Hg]8462-4S
2026-08-24Heart rate72 /min8867-4S
2026-08-24Respiratory rate14 /min9279-1S
2026-08-24Body temperature36.6 Cel8310-5S
2026-08-24Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
A confirmed diagnosis and treatment plan within three weeks2026-03-23completedAChR antibodies, nerve stimulation, chest CT and kidney ultrasound done; generalized MG diagnosed and treatment begun at two weeks
Minimal manifestation status (MG-ADL 0 to 1) within a year, with prednisone at 7.5 mg or less2026-10-12activeMG-ADL 7 at diagnosis, 1 at seven months; prednisone 15 mg and still tapering
No myasthenic crisis, and she knows the warning signs and the medicines to avoid2026-10-12completedNo crisis; FVC 3.25 to 3.62 L; she carries a wallet card and the list of medicines to avoid
Kidney health: eGFR and urine albumin yearly, home blood pressure 110/75 mm Hg or lower if it rises above 130/85, 2 to 3 liters of water a day, and no NSAIDs2026-10-12completedeGFR normal; urine albumin normal; home blood pressure about 116/74 without medicine
Return to full-time work for the Cherokee Nation2026-10-12completedBack at work full time from the seventh month

Interventions

InterventionStatusGuideline
Neuromuscular neurology consultation within two weeks for suspected generalized myasthenia gravis: diagnosis, immunotherapy, thymectomy and safetycompletedGL-MG-2020, GL-MG-2016
Diagnostic tests: acetylcholine receptor binding antibodies (MuSK antibodies if negative), repetitive nerve stimulation (single-fiber EMG if unclear), CT of the chest with contrast for thymoma, TSH, and seated FVC with negative inspiratory forcecompletedGL-MG-2016, GL-MG-2020
Safety: pyridostigmine 30 mg three times daily as a trial; warning signs of myasthenic crisis (breathlessness lying flat, weak cough, trouble swallowing, slurred speech) with emergency care the same day; a wallet card and the list of medicines to avoid, including fluoroquinolones, aminoglycosides, macrolides, magnesium by vein, beta-blockers and telithromycincompletedGL-MG-2016, GL-MGFA-DRUGS
Kidney care for her hereditary polycystic kidney disease: kidney ultrasound with total kidney volume, eGFR and urine albumin, home blood pressure readings, 2 to 3 liters of water a day spread through the day, less salt, and acetaminophen instead of NSAIDscompletedGL-KDIGO-ADPKD-2025
Culturally safe care: laboratory work at a Cherokee Nation Health Services clinic near her home, results shared with this clinic; time given to explain each test and medicine plainly; her own Cherokee medicine respected, with any plant medicine shared so that interactions can be checked, and nothing further askedcompletedGL-CNHS, GL-MG-2016
Immunotherapy: pyridostigmine 60 mg four times daily; prednisone 10 mg each morning rising by 10 mg a week to 40 mg; azathioprine after TPMT activity and hepatitis B and tuberculosis screening, from 50 mg to 150 mg daily; pneumococcal and recombinant zoster vaccines before immunosuppression; no live vaccinescompletedGL-MG-2016, GL-MG-2020, GL-CDC-IMZ-2026
Thymectomy: thoracic surgery assessment for robotic extended thymectomy once she is stable, for AChR antibody-positive generalized MG at 34completedGL-MG-2020, GL-MGTX-2016
Glucocorticoid safety: calcium and vitamin D, DXA within the first months, glucose and hemoglobin A1c, blood pressure and weight at each visit, sleep and mood, eye examination yearly, and Pneumocystis prophylaxis while prednisone is 20 mg or more with azathioprinecompletedGL-ACR-GIOP-2022, GL-MG-2016
Azathioprine monitoring: blood count and liver tests every one to two weeks for the first two months, then every three monthscompletedGL-MG-2016
Newer targeted therapies (efgartigimod, eculizumab or ravulizumab) kept in reserve for refractory disease or intolerance of standard immunotherapy; complement inhibitors would need meningococcal vaccination firstcompletedGL-MG-2020, GL-ADAPT-2021
Standing laboratory orders at the Cherokee Nation Health Services clinic near her home for every azathioprine blood test, with results sent to this clinic and a nurse call for each resultcompletedGL-CNHS, GL-MG-2016

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Wilson LD. Mankiller, Wilma Pearl (1945-2010). The Encyclopedia of Oklahoma History and Culture Oklahoma Historical Society biography
SRC-0002 Brando E. Wilma Mankiller (1945-2010). Biographies National Women's History Museum biography
SRC-0003 Mankiller, Wilma (b. 1945). Encyclopedia of the Great Plains University of Nebraska-Lincoln biography
SRC-0004 Ex-Cherokee chief Mankiller diagnosed with cancer. Cherokee Phoenix, March 3, 2010 Cherokee Phoenix other
SRC-0005 Fighting for her people, her health. News On 6, February 17, 2000 News On 6 (Tulsa) other
SRC-0006 Cherokee Ex-Chief Wilma Mankiller Dies (summary of Associated Press) The Daily Beast other
SRC-0007 Wilma Mankiller, inducted 1994 Oklahoma Hall of Fame biography
SRC-0008 Mankiller, Wilma. UXL Encyclopedia of World Biography (via Encyclopedia.com) Gale, via Encyclopedia.com biography
SRC-0009 Good Voice C. Former Cherokee Nation Chief Wilma Mankiller dies. Cherokee Phoenix, April 6, 2010 Cherokee Phoenix other
SRC-0010 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the slow prednisone rise, azathioprine after TPMT and infection screening, Pneumocystis prophylaxis, early robotic thymectomy at 34 with AChR antibodies and no thymoma, newer targeted therapies held in reserve, the missed early azathioprine blood tests, the ADPKD staging (Mayo 1B, so no tolvaptan) and the decision not to start a blood pressure medicine at normal-high readings.
provenance reviewnot_startedRecent-death rule: only what she made public and what obituaries and reference works reported: the Oklahoma Historical Society, the National Women's History Museum, the Encyclopedia of the Great Plains, the Oklahoma Hall of Fame, Encyclopedia.com, News On 6 (2000) and the Cherokee Phoenix (2010). Her autobiography and the New York Times obituary were not read directly.
safe messaging reviewnot_startedHer husband, daughters, brother and the friend killed in the crash are not named and are given no statement, decision or health fact. The emotional trauma of the crash is recorded as published, marked sensitive, with no diagnosis. Her Cherokee identity and medicine are described without stereotype and without describing any practice.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.